These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1445905

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
    Skrzypczak-Jankun E, Carperos VE, Ravichandran KG, Tulinsky A, Westbrook M, Maraganore JM.
    J Mol Biol; 1991 Oct 20; 221(4):1379-93. PubMed ID: 1942057
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
    Zdanov A, Wu S, DiMaio J, Konishi Y, Li Y, Wu X, Edwards BF, Martin PD, Cygler M.
    Proteins; 1993 Nov 20; 17(3):252-65. PubMed ID: 8272424
    [Abstract] [Full Text] [Related]

  • 4. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A.
    Protein Sci; 1994 Dec 20; 3(12):2254-71. PubMed ID: 7756983
    [Abstract] [Full Text] [Related]

  • 5. Refined structure of the hirudin-thrombin complex.
    Rydel TJ, Tulinsky A, Bode W, Huber R.
    J Mol Biol; 1991 Sep 20; 221(2):583-601. PubMed ID: 1920434
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.
    Matthews JH, Krishnan R, Costanzo MJ, Maryanoff BE, Tulinsky A.
    Biophys J; 1996 Nov 20; 71(5):2830-9. PubMed ID: 8913620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structures of thrombin retro-inhibited with SEL2711 and SEL2770 as they relate to factor Xa binding.
    Mochalkin I, Tulinsky A.
    Acta Crystallogr D Biol Crystallogr; 1999 Apr 20; 55(Pt 4):785-93. PubMed ID: 10089309
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.
    Chen Z, Li Y, Mulichak AM, Lewis SD, Shafer JA.
    Arch Biochem Biophys; 1995 Sep 10; 322(1):198-203. PubMed ID: 7574675
    [Abstract] [Full Text] [Related]

  • 12. Molecular dynamics simulations of thrombin inhibitors at the S' subsites of thrombin.
    Yue SY, Konishi Y.
    Drug Des Discov; 1994 Jul 10; 12(1):1-17. PubMed ID: 7578804
    [Abstract] [Full Text] [Related]

  • 13. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
    Qiu X, Yin M, Padmanabhan KP, Krstenansky JL, Tulinsky A.
    J Biol Chem; 1993 Sep 25; 268(27):20318-26. PubMed ID: 8376390
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
    Féthière J, Tsuda Y, Coulombe R, Konishi Y, Cygler M.
    Protein Sci; 1996 Jun 25; 5(6):1174-83. PubMed ID: 8762149
    [Abstract] [Full Text] [Related]

  • 15. The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8-A resolution.
    Vitali J, Martin PD, Malkowski MG, Robertson WD, Lazar JB, Winant RC, Johnson PH, Edwards BF.
    J Biol Chem; 1992 Sep 05; 267(25):17670-8. PubMed ID: 1517214
    [Abstract] [Full Text] [Related]

  • 16. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
    Wu TP, Yee V, Tulinsky A, Chrusciel RA, Nakanishi H, Shen R, Priebe C, Kahn M.
    Protein Eng; 1993 Jul 05; 6(5):471-8. PubMed ID: 8415574
    [Abstract] [Full Text] [Related]

  • 17. The structure of a complex of recombinant hirudin and human alpha-thrombin.
    Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW.
    Science; 1990 Jul 20; 249(4966):277-80. PubMed ID: 2374926
    [Abstract] [Full Text] [Related]

  • 18. Kinetic mechanism for the interaction of Hirulog with thrombin.
    Parry MA, Maraganore JM, Stone SR.
    Biochemistry; 1994 Dec 13; 33(49):14807-14. PubMed ID: 7993908
    [Abstract] [Full Text] [Related]

  • 19. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E, Elgendy S, Goodwin CA, Green D, Scully MF, Kakkar VV, Freyssinet JM, Dodson G, Deadman JJ.
    Biochemistry; 1998 Oct 13; 37(41):14420-7. PubMed ID: 9772168
    [Abstract] [Full Text] [Related]

  • 20. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
    Tsuda Y, Cygler M, Gibbs BF, Pedyczak A, Féthière J, Yue SY, Konishi Y.
    Biochemistry; 1994 Dec 06; 33(48):14443-51. PubMed ID: 7981204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.